Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epoetin Treatment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT03010579
What this trial is testing

Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
AnemiaLymphomaHematopoietic Stem Cell Transplantation
Peking University 70
Large-scale testing (Phase 3)Study completedNCT00003341
What this trial is testing

Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy

Who this might be right for
AnemiaLeukemiaLymphoma+1 more
Memorial Sloan Kettering Cancer Center 275
Early research (Phase 1)Study completedNCT01685359
What this trial is testing

PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Human Recombinant

Who this might be right for
Healthy
Azidus Brasil 80
Not applicableStudy completedNCT01213485
What this trial is testing

An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Patients With Chronic Kidney Disease on Dialysis (HORTENSIA)

Who this might be right for
Anemia
Hoffmann-La Roche 419
Not applicableEnded earlyNCT01736215
What this trial is testing

An Observational Study to Predict the Response of Erythropoietin Treatment in Participants With Cancer Related Anemia Receiving Chemotherapy

Who this might be right for
Anemia - Cancer Related
Janssen-Cilag Ltd.,Thailand 33
Post-approval studies (Phase 4)Study completedNCT04959578
What this trial is testing

Comparison of Darbepoetin Alpha and Recombinant Human Erythropoietin for Treatment of Anemia in Children With Chronic Kidney Disease

Who this might be right for
Anemia of Chronic Kidney Disease
Rufaida Mazahir 50
Not applicableStudy completedNCT00002073
What this trial is testing

A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of Subcutaneous Doses of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy

Who this might be right for
HIV InfectionsCytopenias
Ortho Pharmaceuticals
Not applicableStudy completedNCT02496377
What this trial is testing

Cross Iron (Comparative Randomized Oral Versus Systemic IRON)

Who this might be right for
Allogenic TransfusionPerioperative AnaemiaKnee Arthroplasty+1 more
University Hospital, Montpellier 100
Post-approval studies (Phase 4)Study completedNCT02707757
What this trial is testing

Treatment Response in Dialysis Anaemia

Who this might be right for
AnaemiaHaemodialysis
Imperial College Healthcare NHS Trust 197
Post-approval studies (Phase 4)Study completedNCT02145026
What this trial is testing

Epoetin Beta Treatment in Anemic Participants With Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic Syndromes
Hoffmann-La Roche 100
Large-scale testing (Phase 3)Study completedNCT04410198
What this trial is testing

Study of Roxadustat Conversion in Participants Receiving Stable Erythropoiesis-Stimulating Agent (ESA) or as Initial Anemia Treatment in Chronic Dialysis Participants

Who this might be right for
Anemia Associated With End Stage Renal Disease (ESRD)
Kyntra Bio 203
Testing effectiveness (Phase 2)Study completedNCT02260193
What this trial is testing

16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Participants With End Stage Renal Disease (ESRD) Requiring Chronic Hemodialysis

Who this might be right for
AnemiaEnd Stage Renal Disease
Akebia Therapeutics 94
Large-scale testing (Phase 3)Ended earlyNCT01288131
What this trial is testing

Study of Anti-r-HuEpo Associated Pure Red Cell Aplasia (PRCA) Treatment

Who this might be right for
Anti-r-HuEpo Associated PRCA Subjects
Chulalongkorn University 8
Testing effectiveness (Phase 2)UnknownNCT04013646
What this trial is testing

Combination Therapy of Umbilical Cord Blood and Erythropoietin for Stroke Paients

Who this might be right for
StrokeUmbilical Cord BloodErythropoietin+2 more
Bundang CHA Hospital 24
Large-scale testing (Phase 3)Looking for participantsNCT07422480
What this trial is testing

Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Who this might be right for
Myelodysplastic SyndromeAnemia
Takeda 300
Large-scale testing (Phase 3)Study completedNCT02273726
What this trial is testing

Study to Evaluate the Efficacy and Safety of Roxadustat in the Treatment of Anemia in Participants With ESRD on Stable Dialysis

Who this might be right for
CKD Anemia in Stable Dialysis Patients
Kyntra Bio 741
Large-scale testing (Phase 3)Study completedNCT00446576
What this trial is testing

The Effect of Epoetin Alfa on Cardiac Function and Quality of Life in Patients With Early Renal ((Kidney) Disease

Who this might be right for
Anemia
Janssen-Cilag B.V. 176
Testing effectiveness (Phase 2)UnknownNCT05629598
What this trial is testing

PEG-EPO Injection (CHO Cells) for Maintenance Therapy of Patients With Renal Anemia .

Who this might be right for
Renal Anemia
Angde Biotech Pharmaceutical Co., Ltd. 150
Testing effectiveness (Phase 2)Study completedNCT01913340
What this trial is testing

Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)

Who this might be right for
Hypoxic-ischemic EncephalopathyNeonatal EncephalopathyBirth Asphyxia
University of California, San Francisco 50
Post-approval studies (Phase 4)Study completedNCT00776425
What this trial is testing

The Quality of Life and Treatment Response to Once Weekly Epoetin Beta (Recormon) Treatment in Anemic Participants With Solid and Lymphoid Malignancies

Who this might be right for
Anemia
Hoffmann-La Roche 117
Next Page